ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Eldad Erez
Eitan Snir
Ehud Raanani
Bernardo A. Vidne
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erez, E.
Right arrow Articles by Vidne, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erez, E.
Right arrow Articles by Vidne, B. A.

Ann Thorac Surg 1998;65:101-106
© 1998 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Thromboxane Production in Human Lung During Cardiopulmonary Bypass: Beneficial Effect of Aspirin?

Eldad Erez, MD, Arie Erman, PhD, Eitan Snir, MD, Ehud Raanani, MD, Dan Abramov, MD, Jacqueline Sulkes, PhD, Geoffrey Boner, MD, Bernardo A. Vidne, MD

Department of Cardiothoracic Surgery, Rabin Medical Center, Beilinson Campus, affiliated to the Sackler School of Medicine, Tel Aviv University, Petach Tikva, Israel
Institute of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, affiliated to the Sackler School of Medicine, Tel Aviv University, Petach Tikva, Israel
Epidemiology Unit, Rabin Medical Center, Beilinson Campus, affiliated to the Sackler School of Medicine, Tel Aviv University, Petach Tikva, Israel

Accepted for publication July 11, 1997.

Dr Vidne, Department of Cardiothoracic Surgery, Rabin Medical Center (Beilinson Campus), Petach Tikva 41900, Israel.

Background. Increased systemic levels of thromboxane (Tx) during cardiopulmonary bypass (CPB) in humans have been reported. It is not known whether this reflects a general systemic response to the surgical procedure or an increased pulmonary production of Tx in response to ischemia and reperfusion.

Methods. Thromboxane B2 levels were measured in the right atrium and left atrium of 14 patients undergoing coronary artery bypass grafting for angina. Eight patients (group 1) were without aspirin for at least 15 days before operation, and 6 patients (group 2) were treated with aspirin (100 mg/day) for at least 1 month before operation. Levels of TxB2 were determined by enzyme immunoassay after lipid extraction and separation.

Results. Thromboxane B2 levels were elevated throughout CPB. In group 1, left atrial TxB2 levels were significantly higher (p < 0.05) than right atrial levels at all study points during CPB. After pulmonary reperfusion, TxB2 levels in both atria increased significantly (p < 0.02) compared with the levels before cross-clamping of the aorta, and there was an increasing gradient between the two atria (p < 0.05). Mean plasma TxB2 levels during CPB in group 2 were significantly reduced (p < 0.0001) in the right atrium (by 73%) and in the left atrium (by 69%) compared with levels in group 1.

Conclusions. The rise in TxB2 levels in the left atrium after CPB in humans reflects production of Tx mainly in the lungs, most probably by ischemic pulmonary tissue and intravascular hematologic components. Aspirin markedly reduces Tx production during CPB, and it might play a major role in preventing pulmonary injury after operations with CPB in humans.




This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. G Raja and G. D Dreyfus
Modulation of Systemic Inflammatory Response after Cardiac Surgery
Asian Cardiovasc Thorac Ann, December 1, 2005; 13(4): 382 - 395.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Massoudy, J. A. Piotrowski, H. C.J.M. van de Wal, R. Giebler, G. Marggraf, J. Peters, and H. G. Jakob
Perfusing and ventilating the patient's lungs during bypass ameliorates the increase in extravascular thermal volume after coronary bypass grafting
Ann. Thorac. Surg., August 1, 2003; 76(2): 516 - 521.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
H. A. Hennein
Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255.
[Abstract] [PDF]


Home page
ChestHome page
P. Massoudy, S. Zahler, B. F. Becker, S. L. Braun, A. Barankay, and H. Meisner
Evidence for Inflammatory Responses of the Lungs During Coronary Artery Bypass Grafting With Cardiopulmonary Bypass
Chest, January 1, 2001; 119(1): 31 - 36.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Pearl, P. B. Manning, J. L. McNamara, M. M. Saucier, and D. W. Thomas
Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass
Ann. Thorac. Surg., October 1, 1999; 68(4): 1369 - 1375.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The Society of Thoracic Surgeons.